Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 12
1988 34
1989 34
1990 57
1991 61
1992 61
1993 74
1994 60
1995 64
1996 116
1997 88
1998 97
1999 162
2000 154
2001 180
2002 254
2003 267
2004 246
2005 284
2006 438
2007 481
2008 436
2009 307
2010 320
2011 358
2012 373
2013 411
2014 441
2015 508
2016 464
2017 418
2018 448
2019 405
2020 410
2021 427
2022 384
2023 345
2024 183

Text availability

Article attribute

Article type

Publication date

Search Results

7,628 results

Results by year

Filters applied: . Clear all
Page 1
Ketamine in neuropsychiatric disorders: an update.
Johnston JN, Kadriu B, Kraus C, Henter ID, Zarate CA Jr. Johnston JN, et al. Neuropsychopharmacology. 2024 Jan;49(1):23-40. doi: 10.1038/s41386-023-01632-1. Epub 2023 Jun 20. Neuropsychopharmacology. 2024. PMID: 37340091 Review.
Psilocybin for treatment resistant depression in patients taking a concomitant SSRI medication.
Goodwin GM, Croal M, Feifel D, Kelly JR, Marwood L, Mistry S, O'Keane V, Peck SK, Simmons H, Sisa C, Stansfield SC, Tsai J, Williams S, Malievskaia E. Goodwin GM, et al. Neuropsychopharmacology. 2023 Sep;48(10):1492-1499. doi: 10.1038/s41386-023-01648-7. Epub 2023 Jul 13. Neuropsychopharmacology. 2023. PMID: 37443386 Free PMC article. Clinical Trial.
Neural circuits regulating prosocial behaviors.
Walsh JJ, Christoffel DJ, Malenka RC. Walsh JJ, et al. Neuropsychopharmacology. 2023 Jan;48(1):79-89. doi: 10.1038/s41386-022-01348-8. Epub 2022 Jun 14. Neuropsychopharmacology. 2023. PMID: 35701550 Free PMC article. Review.
IN MEMORIAM-Jan Fawcett, MD.
Hirschfeld RMA. Hirschfeld RMA. Neuropsychopharmacology. 2022 Sep;47(10):1869-1870. doi: 10.1038/s41386-022-01362-w. Epub 2022 Jun 23. Neuropsychopharmacology. 2022. PMID: 35739256 Free PMC article. No abstract available.
In Memoriam Bernard Agranoff.
Akil H, Fisher SK. Akil H, et al. Neuropsychopharmacology. 2023 Feb;48(3):577. doi: 10.1038/s41386-022-01516-w. Epub 2022 Dec 8. Neuropsychopharmacology. 2023. PMID: 36481848 Free PMC article. No abstract available.
Long-term safety and maintenance of response with esketamine nasal spray in participants with treatment-resistant depression: interim results of the SUSTAIN-3 study.
Zaki N, Chen LN, Lane R, Doherty T, Drevets WC, Morrison RL, Sanacora G, Wilkinson ST, Popova V, Fu DJ. Zaki N, et al. Neuropsychopharmacology. 2023 Jul;48(8):1225-1233. doi: 10.1038/s41386-023-01577-5. Epub 2023 May 12. Neuropsychopharmacology. 2023. PMID: 37173512 Free PMC article. Clinical Trial.
7,628 results